I-ne CO., LTD.
Frequently Asked Questions and Answers Regarding the Second Quarter Financial Results for the Fiscal Year Ending December 2026
In the second quarter of the fiscal year ending December 2026, all categories achieved double-digit Year-over-Year growth. Strong sales from SALONIA and growth in the health supplement brand portfolio are expected to drive higher-than-anticipated revenue and profit. A full-year upward revision has been made. In the second half, while continuing additional investments, the company will factor in profit pressure drivers (costs, FX, investments) and advance measures to prevent recurrence.
Key Figures
- Net Sales: Unknown
- EBITDA: Unknown
- Operating Income: Unknown
AI要約
Business Performance Overview
In the second quarter of the fiscal year ending December 2026, all categories achieved double-digit Year-over-Year growth, resulting in companywide revenue and profit that exceeded expectations. Growth drivers included the health supplement brand portfolio launched in 2025 and a major hit from SALONIA’s face current pointer. On this basis, full-year guidance was revised upward by +3,000 million yen for net sales and +500 million yen each for EBITDA and operating income.
Investment Plan and Outlook
Additional investments in the second half are planned at approximately 3,000–4,000 million yen, and approximately 1,400 million yen was invested in the first half for advertising and promotion. Due to the growth of the health supplement brand portfolio and the strong performance of new beauty appliance products, some of the profit pressure from the additional investments has been offset. In the second half, the company will continue to flexibly invest across categories from the perspective of enhancing mid- to long-term corporate value.
I-ne CO., LTD.
Company overview · Stock price · Financial data · All IR
